Uric acid reducing application of Lactobacillus reuteri HCS02-001 and product of Lactobacillus reuteri HCS02-001
The invention discloses application of lactobacillus reuteri HCS02-001 in reducing uric acid and a product, and relates to the technical field of microorganisms. The invention provides an application of Lactobacillus reuteri HCS02-001 in preparation of a product for treating or preventing hyperurice...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses application of lactobacillus reuteri HCS02-001 in reducing uric acid and a product, and relates to the technical field of microorganisms. The invention provides an application of Lactobacillus reuteri HCS02-001 in preparation of a product for treating or preventing hyperuricemia and/or diseases related to hyperuricemia. The Lactobacillus reuteri HCS02-001 can be used for treating or preventing hyperuricemia and/or diseases related to hyperuricemia. The lactobacillus reuteri HCS02-001 provided by the invention can effectively and obviously reduce the levels of guanosine and inosine, can efficiently relieve or treat hyperuricemia or hyperuricemia-related diseases, can be used for preparing health-care products for maintaining the stability of uric acid, has the advantages of low cost, good safety and good degradation efficiency, and has a wide application prospect.
本发明公开了罗伊氏粘液乳杆菌HCS02-001降尿酸应用及产品,涉及微生物技术领域。本发明提供了罗伊氏粘液乳杆菌HCS02-001在制备治疗或预防高尿酸血症和/或高尿酸血症相关疾病的产品中的应用。本发明提供的罗伊氏粘液乳杆菌HCS02-001能够有 |
---|